60세 이후에 처음 시작한 혈액 투석 환자의 임상적 특징과 예후 (Clinical Features and Prognosis of Patients Who Started Hemodialysis Treatment over 60 Years Old)

서지정보

· 발행기관 : 대한노인병학회
· 수록지 정보 : Annals of geriatric medicine and research / 12권 / 2호 / 95 ~ 101페이지
· 저자명 : 김성훈, 전용덕, 권낙현, 황래석, 강효성, 남기석

초록

Background: Observation on the hemodialysis treatment; whether there are any different effects on mortality rate, side effects, or effectiveness of the treatment depending on patients‘ age.
Methods: Chronic renal failure patients who started hemodialysis treatment between 2002 and 2003 were separated in two groups, 33 patients of 60 and older and 76 patients under 60. We investigated mortality rate difference, A-V shunt re-operation, and total protein and albumin level. Also, comparing and analyzing the urea reduction ratio, we examined whether effectiveness is different depending on the patients’ age.
Results: The 3 year survivor rate of patients who initially started hemodialysis treatment over 60 was 66.7%, and that of the patients under 60 resulted as 73.1%. The average total protein lefel for over 60 was 6.48 g/dL and for under 60 was 6.80 g/dL, and albumin for over 60 was 3.15 g/dL and under 60 was 3.46 g/dL. We identified that the patients who repeated shunt operation in over 60 group was 4 (12%) and in under 60 group was 4 (5.2%). Effectiveness of the treatment, Urea Reduction Ratio (URR), for both groups was 71%.
Conclusion: The 3 year survivor rate of patients who initially started hemodialysis treatment over 60 was
lower than the control group, but considering the remaining life expectancy, it seems to be no significant difference
between the groups; and the treatment effectiveness was same in both groups.

영어초록

Background: Observation on the hemodialysis treatment; whether there are any different effects on mortality rate, side effects, or effectiveness of the treatment depending on patients‘ age.
Methods: Chronic renal failure patients who started hemodialysis treatment between 2002 and 2003 were separated in two groups, 33 patients of 60 and older and 76 patients under 60. We investigated mortality rate difference, A-V shunt re-operation, and total protein and albumin level. Also, comparing and analyzing the urea reduction ratio, we examined whether effectiveness is different depending on the patients’ age.
Results: The 3 year survivor rate of patients who initially started hemodialysis treatment over 60 was 66.7%, and that of the patients under 60 resulted as 73.1%. The average total protein lefel for over 60 was 6.48 g/dL and for under 60 was 6.80 g/dL, and albumin for over 60 was 3.15 g/dL and under 60 was 3.46 g/dL. We identified that the patients who repeated shunt operation in over 60 group was 4 (12%) and in under 60 group was 4 (5.2%). Effectiveness of the treatment, Urea Reduction Ratio (URR), for both groups was 71%.
Conclusion: The 3 year survivor rate of patients who initially started hemodialysis treatment over 60 was
lower than the control group, but considering the remaining life expectancy, it seems to be no significant difference
between the groups; and the treatment effectiveness was same in both groups.

참고자료

· 없음